Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IQCB1 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-09 |
mRNA | HNRNPU | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
mRNA | HNRNPC | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
mRNA | CTSA | CTRPv2 | pan-cancer | AAC | -0.21 | 5e-09 |
mRNA | RBM10 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
mRNA | ANP32E | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
mRNA | ABI3BP | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-09 |
mRNA | RFXAP | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-09 |
mRNA | PTTG1IP | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-09 |
mRNA | SNRPD1 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |